Quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR study

被引:0
|
作者
Karthaus, M. [1 ]
Kretzschmar, A. [2 ]
Welslau, M. [3 ]
Riera-Knorrenschild, J. [4 ]
Kaiser, F. [5 ]
Pelz, H. [6 ]
Ettrich, T. [7 ]
Lindig, U. [8 ]
Schulz, H. [9 ]
von Weikersthal, Fischer L. [10 ]
Kisro, J. [11 ]
de Wit, M. [12 ]
Wiebe, S. [13 ]
Koenigsmann, M. [14 ]
Mahlberg, R. [15 ]
Fuxius, S. [16 ]
Stehle, I [17 ]
Kubicka, S. [18 ]
Schuler, M. K. [19 ]
Schnoy, E. [20 ]
Ruessel, J. [21 ]
Graefe, T. [22 ]
Mayer, F. [23 ]
Berres, M. L. [24 ]
Kubin, T. [25 ]
Heinemann, V [26 ]
机构
[1] Klinikum Neuperlach Klinikum Harlaching, Hamatol & Onkol, Munich, Germany
[2] MVZ Mitte, Leipzig, Germany
[3] Praxis Hamatol & Onkol, Aschaffenburg, Germany
[4] Univ Klin, Giessen, Germany
[5] Praxis Hamatol & Onkol, Landshut, Germany
[6] Ambulantes Therapiezentrum Hamatol & Onkol, Offenburg, Germany
[7] Univ Klin Innere Med, Ulm, Germany
[8] Univ Jena, Med Klin 2, Jena, Germany
[9] PIOH Praxis Internist Onkol & Hamatol, Frechen, Germany
[10] Gesundheitszentrum St Marien, Amberg, Germany
[11] Onkol Schwerpunktpraxis, Lubeck, Germany
[12] Klin Innere Med Hamatol Onkol & Palliat Med, Berlin, Germany
[13] MVZ Media Vita, Munster, Germany
[14] MediProjekt, Hannover, Germany
[15] Klinikum Borromaerinnen, Innere Med 1, Trier, Germany
[16] Tumor Ctr, Heidelberg, Germany
[17] IDGGQ, Kaiserslautern, Germany
[18] Klinikum Steinberg, Reutlingen, Germany
[19] MVZ Oskar Helene Heim, Berlin, Germany
[20] Klinikum Augsburg, Augsburg, Germany
[21] Carl von Basedow Klinikum, Merseburg, Germany
[22] Forsch Gesell Malignitat & Resultate, Hamburg, Germany
[23] Int Gemeinschaftspraxis, Friedrichshafen, Germany
[24] Univ Klin RWTH, Aachen, Germany
[25] Hamatol Onkol Klinikum Traunstein, Traunstein, Germany
[26] Med Klin III, Munich, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ep317
引用
收藏
页码:219 / 219
页数:1
相关论文
共 50 条
  • [21] Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
    Johannes J. M. Kwakman
    G. Vink
    J. H. Vestjens
    L. V. Beerepoot
    J. W. de Groot
    R. L. Jansen
    F. L. Opdam
    H. Boot
    G. J. Creemers
    J. M. van Rooijen
    M. Los
    A. J. E. Vulink
    H. Schut
    E. van Meerten
    A. Baars
    P. Hamberg
    E. Kapiteijn
    D. W. Sommeijer
    C. J. A. Punt
    M. Koopman
    International Journal of Clinical Oncology, 2018, 23 : 482 - 489
  • [22] A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer
    Zou, Jiayun
    Wang, Yuanyuan
    Xu, Jiayu
    Li, Jinna
    Wang, Tianzhuo
    Zhang, Ying
    Bai, Yibo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [23] Sarcopenia in advanced colorectal cancer patients treated with trifluridine/tipiracil
    Malik, M.
    Michalak, M.
    Radecka, B.
    Gelej, M.
    Jackowska, A.
    Filipczyk-Cisarz, E.
    Hetman, K.
    Foszczynska-Kloda, M.
    Kania-Zembaczynska, B.
    Manka, D.
    Orlikowska, M.
    Rogowska-Dros, H.
    Bodnar, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S151 - S151
  • [24] Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany
    Kroening, Hendrik
    Goehler, Thomas
    Decker, Thomas
    Grundeis, Marc
    Kojouharoff, Georgi
    Lipke, Joerg
    Semsek, Dieter
    Moorahrend, Enno
    Sauer, Annette
    Bruch, Harald-Robert
    Liersch, Ruediger
    Nusch, Arnd
    Vehling-Kaiser, Ursula
    Welslau, Manfred
    Grunewald, Ralf
    Harich, Hanns-Detlev
    Stephany, Marcel
    Uhlig, Jens
    de Buhr, Rebecca
    Frank, Melanie
    Hogrefe, Cathrin
    Marschner, Norbert
    Potthoff, Karin
    Hartmann, Frank
    Reislaender, Timo
    Schwaner, Ingo
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (06) : 1227 - 1240
  • [25] Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
    Zaniboni, Alberto
    Barone, Carlo Antonio
    Banzi, Maria Chiara
    Bergamo, Francesca
    Blasi, Livio
    Bordonaro, Roberto
    Di Bartolomeo, Maria
    Di Costanzo, Francesco
    Frassineti, Giovanni Luca
    Garufi, Carlo
    Giuliani, Francesco
    Latiano, Tiziana Pia
    Martinelli, Erika
    Personeni, Nicola
    Racca, Patrizia
    Tamburini, Emiliano
    Tonini, Giuseppe
    Besse, Marie Georges
    Spione, Mario
    Falcone, Alfredo
    FUTURE ONCOLOGY, 2021, 17 (18) : 2315 - 2324
  • [26] Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study
    Kato, Takeshi
    Kagawa, Yoshinori
    Kuboki, Yasutoshi
    Gamoh, Makio
    Komatsu, Yoshito
    Yasui, Hirofumi
    Satake, Hironaga
    Oki, Eiji
    Tanioka, Hiroaki
    Kotaka, Masahito
    Makiyama, Akitaka
    Denda, Tadamichi
    Goto, Masahiro
    Yoshino, Takayuki
    Yamazaki, Kentaro
    Soeda, Junpei
    Shibuya, Kazunori
    Iwata, Masaru
    Oba, Koji
    Yamaguchi, Kensei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (07) : 1238 - 1247
  • [27] Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study
    Takeshi Kato
    Yoshinori Kagawa
    Yasutoshi Kuboki
    Makio Gamoh
    Yoshito Komatsu
    Hirofumi Yasui
    Hironaga Satake
    Eiji Oki
    Hiroaki Tanioka
    Masahito Kotaka
    Akitaka Makiyama
    Tadamichi Denda
    Masahiro Goto
    Takayuki Yoshino
    Kentaro Yamazaki
    Junpei Soeda
    Kazunori Shibuya
    Masaru Iwata
    Koji Oba
    Kensei Yamaguchi
    International Journal of Clinical Oncology, 2021, 26 : 1238 - 1247
  • [28] The REWRITE Study-REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer
    Marques, D.
    Costa, A. L.
    Mansinho, A.
    Quintela, A.
    Pratas, E.
    Brito-da-Silva, J.
    Cruz, J.
    Felix, J.
    Rodrigues, J.
    Mota, M.
    Teixeira, A. R.
    Damaso, S.
    Pinheiro, S.
    Andreozzi, V.
    Costa, L.
    Barros, A. G.
    CLINICAL ONCOLOGY, 2023, 35 (10) : 665 - 672
  • [29] Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab
    Kamiimabeppu, Daisaku
    Osumi, Hiroki
    Shinozaki, Eiji
    Ooki, Akira
    Wakatsuki, Takeru
    Yoshino, Koichiro
    Sato, Taro
    Nakayama, Izuma
    Ogura, Mariko
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [30] A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
    Borelli, Beatrice
    Zucchelli, Gemma
    Rossini, Daniele
    Cremolini, Chiara
    Antoniotti, Carlotta
    Moretto, Roberto
    Marmorino, Federica
    Colombo, Camilla
    Vannini, Francesca
    Delliponti, Laura
    Spione, Mario
    Ongaro, Elena
    Masi, Gianluca
    Brunetti, Isa Maura
    Pfanner, Elisabetta
    Salvatore, Lisa
    Falcone, Alfredo
    COLORECTAL CANCER, 2018, 7 (01)